Machine Learning Helps Identify Patterns of Progression in ALS
https://unsplash.com/photos/w7ZyuGYNpRQ

Machine Learning Helps Identify Patterns of Progression in ALS

According to a story from myscience.org, neurodegenerative diseases, such as amyotrophic lateral sclerosis, are diseases that progressively worsen over time. However, progression in this disease is not consistent across all…

Continue Reading Machine Learning Helps Identify Patterns of Progression in ALS
A New Treatment for Amyotrophic Lateral Sclerosis Gets Approved, but Trial Results Are Spotty
source: pixabay.com

A New Treatment for Amyotrophic Lateral Sclerosis Gets Approved, but Trial Results Are Spotty

According to a story from CNN, a new treatment was recently approved by the US Food and Drug Administration (FDA) for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's…

Continue Reading A New Treatment for Amyotrophic Lateral Sclerosis Gets Approved, but Trial Results Are Spotty
Two Studies Lead to Possible Therapeutic Approach for Neurodegenerative Diseases
source: pixabay.com

Two Studies Lead to Possible Therapeutic Approach for Neurodegenerative Diseases

  The loss of axons (nervous system wiring) has been responsible for various neurodegenerative diseases such as peripheral neuropathies, Parkinson’s disease, glaucoma, and amyotrophic lateral sclerosis (ALS). According to a…

Continue Reading Two Studies Lead to Possible Therapeutic Approach for Neurodegenerative Diseases

Will This Novel Drug That Utilizes AI Succeed in Having an Impact on ALS When so Many Others Have Failed?

Verge Genomics, based in San Francisco is one of a series of biotechs that have entered into a new era using AI in drug discovery. The company is backed by…

Continue Reading Will This Novel Drug That Utilizes AI Succeed in Having an Impact on ALS When so Many Others Have Failed?
Amyotrophic Lateral Sclerosis Patients Have an Alternative to Radicava ORS via IV
qimono / Pixabay

Amyotrophic Lateral Sclerosis Patients Have an Alternative to Radicava ORS via IV

The new FDA-approved oral formulation of  Radicava ORS (edaravone) is more convenient than the intravenous formulation, yet the efficacy and composition remain the same. The oral formulation may also be…

Continue Reading Amyotrophic Lateral Sclerosis Patients Have an Alternative to Radicava ORS via IV
May is Amyotrophic Lateral Sclerosis Awareness Month: Spreading Rare Disease Awareness
source: pixabay.com

May is Amyotrophic Lateral Sclerosis Awareness Month: Spreading Rare Disease Awareness

According to a story from ALS News Today, around 5,000 people get diagnosed with amyotrophic lateral sclerosis (ALS) annually. In addition, costs of treatment for patients average $250,000 out of…

Continue Reading May is Amyotrophic Lateral Sclerosis Awareness Month: Spreading Rare Disease Awareness
The House Passes a New Act Which Will Accelerate Research for ALS and Related Diseases
source: pixabay.com

The House Passes a New Act Which Will Accelerate Research for ALS and Related Diseases

Three organizations focused on amytrophic lateral sclerosis (ALS) as well as other rare neurodegenerative diseases, have just celebrated the House of Representatives' passage of the ACT for ALS (H.R.3537/S.1813). The…

Continue Reading The House Passes a New Act Which Will Accelerate Research for ALS and Related Diseases